On the contrary, CD9 appears to be a significant element in leukemic cell development, and its expression is upregulated in CD34+ cells from patients affected by myeloid neoplasms [21] and in multiple myeloma cells [18]. The gene discussed is CD9; the disease is myeloid neoplasm.